HEPATOLOGY
Scope & Guideline
Transforming liver health with groundbreaking insights.
Introduction
Aims and Scopes
- Viral Hepatitis Research:
This area includes studies on the epidemiology, pathogenesis, and treatment of hepatitis viruses (A, B, C, D, and E), focusing on novel antiviral therapies and their clinical implications. - Liver Cancer and Oncology:
Research on hepatocellular carcinoma (HCC) and cholangiocarcinoma, including mechanisms of tumorigenesis, therapeutic strategies, and outcomes of various treatment modalities. - Liver Disease Mechanisms:
Investigations into the cellular and molecular mechanisms underlying liver diseases such as non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, and autoimmune liver conditions. - Transplantation and Regenerative Medicine:
Studies focused on liver transplantation, including donor selection, post-transplant outcomes, and the role of stem cells and organoids in liver regeneration. - Clinical Guidelines and Practice:
The journal publishes consensus guidelines and practice recommendations to improve the management of liver diseases, emphasizing evidence-based approaches. - Innovative Diagnostic Techniques:
Research utilizing advanced diagnostic modalities such as imaging techniques, serum biomarkers, and non-invasive fibrosis assessment methods for better disease characterization. - Public Health and Epidemiology:
Articles addressing the epidemiological aspects of liver diseases, including the impact of lifestyle factors, health disparities, and public health initiatives for prevention and management.
Trending and Emerging
- Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD):
Research on MAFLD is gaining momentum, emphasizing the need for updated diagnostic criteria and treatment strategies that address the metabolic aspects of liver disease. - Artificial Intelligence in Hepatology:
The integration of AI and machine learning techniques for diagnosing liver diseases, predicting outcomes, and personalizing treatment regimens is becoming increasingly prominent. - Personalized Medicine Approaches:
Emerging studies focusing on tailoring therapies based on individual patient characteristics, genetic profiles, and specific disease phenotypes are trending. - Non-Invasive Diagnostic Modalities:
There is a marked increase in research on non-invasive techniques for diagnosing liver conditions, including transient elastography, MRI-based assessments, and blood-based biomarkers. - Gut-Liver Axis Research:
The exploration of the gut microbiome's role in liver disease pathogenesis and treatment responses is an emerging area of interest, linking gastrointestinal health to liver outcomes. - Longitudinal Studies and Real-World Evidence:
There is a growing trend towards longitudinal studies that provide real-world evidence on the effectiveness of therapies and the natural history of liver diseases. - Public Health Interventions:
Research focusing on the impact of public health policies and community-based interventions for liver disease prevention and management is gaining traction.
Declining or Waning
- Traditional Liver Biopsy Techniques:
There has been a noticeable decline in studies focused on traditional liver biopsy methods as non-invasive techniques for assessing liver fibrosis gain popularity and acceptance. - Alcohol-Induced Liver Disease:
Although still an important topic, research specifically focused on classic alcohol-induced liver disease may be waning as attention shifts towards broader metabolic dysfunction-associated liver diseases (MASH) and their multifactorial causes. - Basic Science Studies:
The journal has seen fewer purely basic science studies as there is a growing emphasis on translational research that can directly impact clinical practice and patient care. - Viral Hepatitis Monotherapy Studies:
Research focusing solely on monotherapy for hepatitis treatments is declining in favor of combination therapies that target multiple pathways and improve treatment efficacy. - Outdated Diagnostic Biomarkers:
Research on older biomarkers for liver disease diagnosis is decreasing as newer, more effective biomarkers are developed and validated.
Similar Journals
JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Pioneering research for a healthier digestive future.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Exploring breakthroughs in gastroenterology and hepatology.Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.
LIVER INTERNATIONAL
Bridging the gap between research and clinical practice in liver health.LIVER INTERNATIONAL, with its ISSN 1478-3223 and E-ISSN 1478-3231, is a prestigious peer-reviewed journal published by Wiley in the United Kingdom. Established in 2003, it focuses on advancing the field of hepatology, covering a broad spectrum of topics including liver disease, hepatocellular carcinoma, and transplantation. Ranking #10 out of 82 in the Scopus category for Medicine - Hepatology and boasting a remarkable 88th percentile, LIVER INTERNATIONAL has secured its reputation as a leading journal, recognized as Q1 in the 2023 category quartiles. The journal emphasizes accessibility, offering an open access option to ensure that critical research findings reach a wider audience. By facilitating the dissemination of high-quality research, LIVER INTERNATIONAL plays a vital role in shaping contemporary hepatological discourse and bridging academic inquiry with clinical practice, making it an essential resource for researchers, healthcare professionals, and students alike.
HEPATOLOGY RESEARCH
Bridging research and practice for improved patient outcomes.Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.
International Journal of Hepatology
Empowering global knowledge in liver health.The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.
DIGESTIVE AND LIVER DISEASE
Exploring the frontiers of digestive and liver health.DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
Empowering Knowledge in Gastrointestinal and Liver PhysiologyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.
Saudi Journal of Gastroenterology
Championing open access to vital gastroenterological findings.The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.
World Journal of Hepatology
Leading the way in hepatology research and education.World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.